E-scooter crashes: why UK trauma centres are treating a growing number of injured children

Three major trauma centres in the north of England — in Liverpool, Manchester and Sheffield — say they have treated nearly 500 casualties under the age of 16 from e-scooter crashes, with some of the injured children as young as nine. The figures, drawn from hospitals that handle some of the most serious injury cases in their regions, point to a growing pattern that trauma doctors say deserves far more attention from parents, retailers and regulators alike.
E-scooters have become a familiar sight on British streets and pavements over the past several years, driven by their low cost, ease of use and appeal as a quick way to get around — or, for many younger riders, simply as a fun way to play outside. That popularity has a darker side, according to the trauma centres, which describe a steady rise in the number of children arriving in emergency departments with injuries sustained while riding one.
The injuries trauma teams are treating range from fractures to more serious head trauma, the kind of harm consistent with a rider losing control at speed and being thrown from the scooter or colliding with a vehicle, kerb or pedestrian. Children are particularly vulnerable to this type of crash: their coordination, reaction times and sense of risk are still developing, and e-scooters, with their small wheels and narrow platforms, can pitch a rider forward abruptly when a wheel catches on a pothole, crack or raised paving stone — a hazard that matters far less on a bicycle with larger wheels and a rider in a seated, more stable position.
The rise in child casualties sits inside an unusual legal landscape. Private e-scooters remain illegal to ride on public roads and pavements across most of the UK; only scooters rented through officially licensed trial schemes in certain towns and cities are legal to use in public. In practice, however, privately owned e-scooters are widely available to buy and are commonly ridden by children on streets and pavements regardless of the legal restrictions, creating a gap between the law as written and how the scooters are actually used.
Part of what's driving the trend, trauma doctors and safety campaigners say, is how easy e-scooters are to obtain. They are sold openly online and in shops as a mainstream consumer product, often marketed as suitable for younger riders, with little in the way of built-in safeguards to prevent a nine- or ten-year-old from riding one at speed on a public street without a helmet or other protective gear.
Clinicians treating these injuries draw a direct comparison with cycling, where decades of safety campaigning, dedicated infrastructure and near-universal helmet advice have shaped how children are taught to ride. E-scooters, by contrast, have arrived on the market and into children's hands faster than public safety messaging, protective equipment norms or road infrastructure have been able to keep pace, leaving a gap that trauma teams say shows up directly in emergency admissions.
The pattern reported by the Liverpool, Manchester and Sheffield trauma centres reflects a wider trend being observed at major trauma units elsewhere in the country, rather than a problem confined to those three cities. As e-scooter ownership has grown nationally, so too has the volume of scooter-related injury cases reaching hospital emergency and trauma departments, according to clinicians working in the field.
Trauma doctors are urging parents to treat e-scooters with the same level of caution as any other fast-moving vehicle, rather than as a toy. Their recommendations echo standard advice for wheeled recreational activities: a properly fitted helmet at minimum, wrist and knee protection where possible, riding only in appropriate, low-traffic areas away from roads, and close adult supervision for younger children who may not yet have the judgement to gauge speed, distance or an approaching hazard.
The clinical data has also fed into a broader debate about whether current regulation is fit for purpose. Health professionals treating these injuries have called for clearer rules — potentially including minimum age requirements, mandatory safety standards for scooters marketed at children, and better public information about the legal restrictions on where private e-scooters can and can't be ridden — arguing that relying on an unenforced ban has done little to keep young riders off busy pavements and roads.
For now, the trauma centres say their message to parents is straightforward: an e-scooter can reach speeds that make a fall genuinely dangerous, particularly for a child's still-developing body, and the nearly 500 cases they've treated between them represent real, largely preventable injuries. Simple precautions — a helmet, a safer riding environment and close supervision — could meaningfully reduce how many of those cases keep arriving in emergency departments.
Read next

Polio vaccination in Kashmir: the women trekking miles to reach the last unvaccinated children
In the mountain villages of Pulwama, Kashmir, health workers Shameema and Tanzeela carry insulated vaccine boxes for miles each morning, keeping doses between 2C and 8C as summer temperatures climb to 37C. Their work is part of a vast national campaign to vaccinate every child in India against polio, however remote.

What are organoids, and why UK scientists are growing miniature human organs for drug testing
A new £20m project based in Cambridge is growing miniature human organs and tissues from NHS patients' cells, aiming to improve drug testing and reduce the number of animals used. These lab-grown tissue fragments, called organoids, mimic the structure of a real organ and help researchers understand how a disease varies between patients, and which treatment works best for whom.

Should older adults stop taking statins? What a new study found
Millions of older adults take cholesterol-lowering statins for decades without interruption. A new study found that stopping statins in people over 75 at low risk for heart disease did not increase deaths. The findings apply only to the low-risk, primary-prevention group, not people who have already had a heart attack or stroke.

Full-fat dairy: why new research is challenging decades of low-fat advice
For decades, dietary guidelines have pushed adults toward low-fat dairy. A new 12-week study found no meaningful increases in weight, body fat, cholesterol or insulin resistance among adults eating three servings of full-fat dairy daily. Participants also saw improved blood pressure and consumed more calcium, protein and vitamin D.

Lp(a): the hidden genetic heart-disease risk most people never test for
Lipoprotein(a), or Lp(a), is an inherited, cholesterol-related particle that a new study of more than 20,000 people links to a sharply higher risk of stroke and cardiovascular death. Unlike standard cholesterol, Lp(a) levels are set almost entirely by genetics and rarely show up on a routine blood panel.